Biosimilar Market Report 2021: Exponential Growth by Market Size, Share, Trends and Analysis to 2027 in UK

August 04 14:43 2021
Biosimilar Market Report 2021: Exponential Growth by Market Size, Share, Trends and Analysis to 2027 in UK

Biosimilar Market
Biosimilar is a biologic medical product, which is similar to the originator biologic products. As per the European Medicines Agency (EMA), a biosimilar is a biomedicine that has the same characteristics as the biomedicines licensed in the European Union (EU).

Biosimilar Market:

The global biosimilar market was valued at USD 4.49 billion in 2017 and is anticipated to reach USD 22.43 billion by 2023 at a CAGR of 30.9%. 

Global Biosimilar Market,’ has been analyzed during this report with the intention of helping aspiring players, accurate analysis of the estimated market size, share, revenue, and sales & distribution networks of the global Biosimilar Market over the forecast period (2021-2027). On the entire, it’s beginning as a useful guideline for readers to know the market and make powerful strategies to place up a robust competition.

Get a Sample Copy of this report with the latest Industry trends and COVID-19 Impact:

The Major Players Covered in this Report: Biocon, Pfizer, Inc., Intas Pharmaceuticals Ltd., Dr. Reddy’s Laboratories Ltd., Sandoz International GmbH (A Novartis Division), Celltrion Inc., Teva Pharmaceutical Industries Ltd., STADA Arzneimittel AG, Amgen, Inc., and Apotex Inc. (Apobiologix), & more…

Biosimilar Market Segmentation:
By Product: Recombinant Non-Glycosylated Proteins, Recombinant Glycosylated Proteins, Recombinant Peptides

By Disease: Oncology, Autoimmune Diseases, Chronic Diseases, Blood Disorders, Growth Hormone Deficiency, Infectious Diseases, Other Diseases

Years that have been considered for the study of this report are as follows:

  • History Year: 2015-2019
  • Base Year: 2019
  • Estimated Year: 2020
  • Forecast Year: 2021 to 2027

Buy Full Report with Detail Analysis with COVID-19 Impact –

Growing Domestic Demand and Expanding Pharmaceutical Sector to Drive the Demand for Biosimilar in the APAC Region:
Asia-Pacific region is anticipated to hold the largest market share in the global Biosimilar market during the forecast period 2021-2027. The growth in this region can be attributed to the presence of emerging economies like India, China, Japan, Vietnam, and Indonesia, which account for the largest share in this region. India is one of the largest producers of Biosimilar and a major exporter of the product to various countries across the globe.

Full Report Link @ 

Multiple Stakeholders to Influence the Use of Biosimilar:
The participation of the insurers, purchasers, integrated delivery networks, and physicians in quality- and outcomes-based payment structures is fueling the adoption of biosimilars. Additionally, the integrated health systems are encouraging more patients to take a paradigm shift towards the adoption of biosimilars for the treatment of several diseases.

Providing Better Services for Brand Recognition:
Healthcare companies are arduously working to retain their market position by developing innovative products. The companies are also providing a number of services, including patient education, mobile apps, and financial assistance, to create a brand identity and increase the consumer base.

Our Report Covers:

  • Historical inferences, findings & analysis of the market from 2016–2018
  • Projections and performance forecast analysis for the future from 2019–2026
  • Production and consumption point of view (POV) analysis
  • Market drivers, restraint and opportunity analysis, to define market dynamics covering industry, regulatory, innovation, technological & pricing trends
  • Comprehensive competitive landscape mapping with recent development covering market leadership, competency, sustainability, and prospects

Would you like to discuss Biosimilar Market challenges with the experts at Straits Research?

Media Contact
Company Name: Straitsresearch
Contact Person: Riya
Email: Send Email
Phone: 6464807505
Address:825 3rd Avenue New York, NY, USA, 10022
City: New York
State: United States
Country: United States